Works by Tsutomu Tabata

Results: 80
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    COVID-19 mRNA vaccination status and concerns among pregnant women in Japan: a multicenter questionnaire survey.

    Published in:
    BMC Pregnancy & Childbirth, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12884-023-05669-4
    By:
    • Takahashi, Ken;
    • Samura, Osamu;
    • Hasegawa, Akihiro;
    • Okubo, Haruna;
    • Morimoto, Keiji;
    • Horiya, Madoka;
    • Okamoto, Aikou;
    • Ochiai, Daigo;
    • Tanaka, Mamoru;
    • Sekiguchi, Masaki;
    • Miyasaka, Naoyuki;
    • Suzuki, Yuto;
    • Tabata, Tsutomu;
    • Hayata, Eijiro;
    • Nakata, Masahiko;
    • Suzuki, Tomoo;
    • Nishi, Hirotaka;
    • Toda, Yumi;
    • Tanigaki, Shinji;
    • Furuya, Natsumi
    Publication type:
    Article
    12
    13

    A Japanese survey of malignant disease in pregnancy.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 3, p. 328, doi. 10.1007/s10147-018-1352-x
    By:
    • Kobayashi, Yoshiyuki;
    • Tabata, Tsutomu;
    • Omori, Mayu;
    • Kondo, Eiji;
    • Hirata, Toru;
    • Yoshida, Kenta;
    • Sekine, Masayuki;
    • Itakura, Atsuo;
    • Enomoto, Takayuki;
    • Ikeda, Tomoaki
    Publication type:
    Article
    14
    15

    Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial).

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 1, p. 103, doi. 10.1007/s10147-018-1319-y
    By:
    • Komiyama, Shinichi;
    • Kato, Kazuyoshi;
    • Inokuchi, Yuki;
    • Takano, Hirokuni;
    • Matsumoto, Takashi;
    • Hongo, Atsushi;
    • Asai-Sato, Mikiko;
    • Arakawa, Atsushi;
    • Kamiura, Shoji;
    • Tabata, Tsutomu;
    • Takeshima, Nobuhiro;
    • Sugiyama, Toru
    Publication type:
    Article
    16

    Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer.

    Published in:
    International Journal of Clinical Oncology, 2018, v. 23, n. 2, p. 201, doi. 10.1007/s10147-017-1193-z
    By:
    • Saito, Toshiaki;
    • Tabata, Tsutomu;
    • Ikushima, Hitoshi;
    • Yanai, Hiroyuki;
    • Tashiro, Hironori;
    • Niikura, Hitoshi;
    • Minaguchi, Takeo;
    • Muramatsu, Toshinari;
    • Baba, Tsukasa;
    • Yamagami, Wataru;
    • Ariyoshi, Kazuya;
    • Ushijima, Kimio;
    • Mikami, Mikio;
    • Nagase, Satoru;
    • Kaneuchi, Masanori;
    • Yaegashi, Nobuo;
    • Udagawa, Yasuhiro;
    • Katabuchi, Hidetaka
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, n. 5, p. 1, doi. 10.3802/jgo.2024.35.e114
    By:
    • Daisuke Aoki;
    • Tsutomu Tabata;
    • Satoshi Yanagida;
    • Toshiaki Nakamura;
    • Eiji Kondo;
    • Junzo Hamanishi;
    • Kenichi Harano;
    • Kosei Hasegawa;
    • Takeshi Hirasawa;
    • Kensuke Hori;
    • Shinichi Komiyama;
    • Motoki Matsuura;
    • Hidekatsu Nakai;
    • Hiroko Nakamura;
    • Jun Sakata;
    • Kazuhiro Takehara;
    • Munetaka Takekuma;
    • Yoshihito Yokoyama;
    • Yoichi Kase;
    • Shuuji Sumino
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36

    Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer.

    Published in:
    Journal of Gynecologic Oncology, 2021, v. 32, n. 2, p. 1, doi. 10.3802/jgo.2021.32.e16
    By:
    • Aikou Okamoto;
    • Eiji Kondo;
    • Toshiaki Nakamura;
    • Satoshi Yanagida;
    • Junzo Hamanishi;
    • Kenichi Harano;
    • Kosei Hasegawa;
    • Takeshi Hirasawa;
    • Kensuke Hori;
    • Shinichi Komiyama;
    • Motoki Matsuura;
    • Hidekatsu Nakai;
    • Hiroko Nakamura;
    • Jun Sakata;
    • Tsutomu Tabata;
    • Kazuhiro Takehara;
    • Munetaka Takekuma;
    • Yoshihito Yokoyama;
    • Yoichi Kase;
    • Shuuji Sumino
    Publication type:
    Article
    37
    38

    The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG.

    Published in:
    Journal of Gynecologic Oncology, 2020, v. 31, n. 6, p. 1, doi. 10.3802/jgo.2020.31.e94
    By:
    • Eiji Kondo;
    • Tsutomu Tabata;
    • Nao Suzuki;
    • Daisuke Aoki;
    • Hideaki Yahata;
    • Yoshio Kotera;
    • Osamu Tokuyama;
    • Keiichi Fujiwara;
    • Eizo Kimura;
    • Fumitoshi Terauchi;
    • Toshiyuki Sumi;
    • Aikou Okamoto;
    • Nobuo Yaegashi;
    • Takayuki Enomoto;
    • Toru Sugiyama
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46

    The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.

    Published in:
    2017
    By:
    • Takekuma, Munetaka;
    • Mori, Keita;
    • Iida, Tetsuji;
    • Kurihara, Kazuko;
    • Saitou, Motoaki;
    • Tokunaga, Hideki;
    • Kawana, Kei;
    • Ikeda, Masae;
    • Satoh, Toyomi;
    • Saito, Toshiaki;
    • Miyagi, Etsuko;
    • Nagai, Yutaka;
    • Furusawa, Akiko;
    • Kawano, Yoshiaki;
    • Kawano, Kouichiro;
    • Tabata, Tsutomu;
    • Ota, Yukinobu;
    • Hayase, Ryoji;
    • Mikami, Mikio;
    • Sugiyama, Toru
    Publication type:
    journal article
    47
    48

    Reply.

    Published in:
    2010
    By:
    • Ueno, Hiroki;
    • Koyama, Hidenori;
    • Tabata, Tsutomu;
    • Nishizawa, Yoshiki
    Publication type:
    Letter
    49
    50